Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
VanEck Semiconductor ETF
SMH
Invesco Solar ETF
TAN
4
Direxion Daily Energy Bull 2X Shares ETF
ERX
5
The Technology Select Sector SPDR® Fund
XLK
US Stock MarketDetailed Quotes
Sanofi (SNY)
- 42.690
- -0.160-0.37%
Close May 15 16:00 ET
- 42.690
- 0.0000.00%
Post 16:10 ET
102.28BMarket Cap11.82P/E (TTM)
43.210High42.670Low2.69MVolume43.020Open42.850Prev Close115.36MTurnover0.12%Turnover Ratio11.49P/E (Static)2.40BShares50.55552wk High1.20P/B92.34BFloat Cap41.04352wk Low2.24Dividend TTM2.16BShs Float54.556Historical High5.24%Div Yield TTM1.26%Range %8.028Historical Low42.890Avg Price1Lot Size
SNY Stock Chart
After-Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
SNY Orderflow
Unit: --
SNY Orderflow Trend
IntradayDayWeekMonth
No Data
Sanofi (SNY) News
FDA Leadership Fallout Continues as Acting CDER Director Hoeg Expected to Depart
Real-World Dupixent Data in Canada: What Regeneron and Sanofi Investors Should Watch
Express News | Shah Capital Management: Beheve Covid/Flu Combo Phase 3 Either Through Sanofi or Novavax's Own (Creative Partnership) Must Start Immediately
Biopharmas Look to China, Elsewhere for Partnerships, R&D
Sanofi's SAR445399 Lung Trial Moves Ahead: What Investors Should Watch
Pharmaceutical Drug Delivery Market Worth $2,922.82 Billion by 2031 | MarketsandMarkets
Sanofi (SNY) Stock Forum
$Dermata Therapeutics (DRMA.US)$
Bullish Equity Research Report
Dermata Therapeutics, Inc. (NASDAQ: DRMA)
Date: February 11, 2026
Current Price: $1.69
Shares Outstanding: ~3.2 Million
Cash Balance: Over $8 Million
Analyst Coverage: Strong Buy – $10 Price Target
🚀 Investment Thesis
Dermata Therapeutics (DRMA) is approaching a potential major inflection point as it transitions from a development-stage biotech into a commercial-stage OTC dermatology company targeting the ...
Bullish Equity Research Report
Dermata Therapeutics, Inc. (NASDAQ: DRMA)
Date: February 11, 2026
Current Price: $1.69
Shares Outstanding: ~3.2 Million
Cash Balance: Over $8 Million
Analyst Coverage: Strong Buy – $10 Price Target
🚀 Investment Thesis
Dermata Therapeutics (DRMA) is approaching a potential major inflection point as it transitions from a development-stage biotech into a commercial-stage OTC dermatology company targeting the ...
28
16
1
$Sanofi (SNY.US)$ why cant i buy this stock?
1
1
$Sanofi (SNY.US)$ haha why this stock like no one here
1
2
The 2026 J.P. Morgan Healthcare Conference served as the global pharmaceutical industry’s premier strategic roadshow. It revealed a shared, critical concern among industry titans: under the pressure of looming patent cliffs for marquee drugs, how can they engineer new engines for growth? Their strategic choices not only determine their own fates but also map out the industry trends and investment directions f...
+3
8
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)
70178686 : It can drop to 0.5 and then rise to 5. Can you handle the volatility?
Hwang Wei Lin 70178686 : Never happened how could it? if you said 2.10 i believe on maybe 10% . You must blend in all the improvements they have done.
老板画的饼 : Not just 10 times, but 100 times the return, though it will take five years
Hwang Wei Lin 老板画的饼 : Too far to see how they play. One thing I discovered is that this stock is totally different from other stock plays. do you realize that? The unique thing that lures investors to come in, is the price of this stock is cheap price.
75189397 : could of should of would of
View more comments...